U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07355361) titled 'Huaier Granule and Proteinuria' on Jan. 13.
Brief Summary: The goal of this clinical trial is to learn if adding Huaier Granule to standard care can treat proteinuria (excess protein in the urine) in adult female breast cancer patients (aged 18-75) who developed this condition as a side effect of their immunotherapy or anti-angiogenic cancer treatment.
The main question it aims to answer is:
* Does the addition of Huaier Granule to standard care improve the effectiveness of proteinuria treatment after 8 weeks?
Researchers will compare the group receiving standard care plus Huaier Granule to the group receiving standard care alone...